Patents by Inventor Y. Tom Tang

Y. Tom Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050069876
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: March 29, 2002
    Publication date: March 31, 2005
    Applicant: Incyte Corporation
    Inventors: Mariah Baughn, Neil Burford, Li Ding, Brendan Duggan, Vicki Elliott, Ian Forsythe, Ameena Gandhi, Kimberly Gietzen, Jennifer Griffin, Ann He, Cynthia Honchell, Craig Ison, Preeti Lal, Ernestine Lee, Sally Lee, Dyung Alina Lu, Patricia Mason, Madhusudan Sanjanwala, Anita Swarnakar, Jayalaxmi Ramkumar, Y Tom Tang, Kavitha Thangavelu, Uyen Tran, Narinder Chawla, Bridget Warren, Monique Yao, Yuming Xu, Henry Yue
  • Patent number: 6872560
    Abstract: The invention provides human hydrolytic enzymes (HYENZ) and polynucleotides which identify and encode HYENZ. The invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HYENZ.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: March 29, 2005
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Jennifer L. Hillman, Y. Tom Tang, Mariah R. Baughn, Dyung Aina M. Lu, Yalda Azimazai
  • Publication number: 20050048490
    Abstract: Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides whichidentify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
    Type: Application
    Filed: September 26, 2002
    Publication date: March 3, 2005
    Applicant: incyte corp.
    Inventors: Yalda Azimzai, Mariah Baughn, Shanya Becha, Mark Borowsky, Narinder Chawla, Vicki Elliott, Brooke Emerling, Ameena Gandhi, Kimberly Gietzen, Ann Gorvad, Jennifer Griffin, April Hafalia, Craig Ison, Amu Kable, Daniel Kalafus, Patircia Lehr-Mason, Dyung Aina Lu, Joseph Marquis, Danniel Nguyen, Jayalaxmi Ramkumar, Thomas Richardson, Stephanie Kareht, Anita Swarnakar, Y Tom Tang, Uyen Tran, Bridget Warren, Yuming Xu, Monique Yao, Huibin Yue, Henry Yue
  • Patent number: 6855811
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: February 15, 2005
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah
  • Patent number: 6838241
    Abstract: The invention provides human protein transport molecules (PTAM) and polynucleotides which identify and encode PTAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PTAM.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: January 4, 2005
    Assignee: Incyte Corporation
    Inventors: Y. Tom Tang, Preeti Lal, Olga Bandman, Henry Yue, Neil C. Corley, Karl J. Guegler, Gina A. Gorgone, Mariah R. Baughn, Chandra Patterson
  • Publication number: 20040265807
    Abstract: The invention provides human enzymes (NZMS) and polynucleotides which identify and encode NZMS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NZMS.
    Type: Application
    Filed: March 8, 2004
    Publication date: December 30, 2004
    Inventors: Madhusudan M Sanjanwala, Yan Lu, Ernestine A Lee, April J A Hafalia, Bridget A Warren, Mariah R Baughn, Y Tom Tang, Henry Yue, Monique G Yao, Sally Lee, Michael B Thornton, Narinder K Chawla, Yuming Xu, Uyen K Tran, Preeti G Lal, Dyung Aina M Lu, Anita Swarnakar, Huijun Z Ring, Karen A Jones
  • Publication number: 20040258679
    Abstract: The invention provides human vesicle-associated proteins (VAP) and polynucleotides which identify and encode VAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of VAP.
    Type: Application
    Filed: March 29, 2004
    Publication date: December 23, 2004
    Inventors: Bridget A Warren, Kavitha Thangavelu, Henry Yue, Soo Yeun Lee, Y Tom Tang, Mariah R Baughn, Vicki S Elliott, Brooke M Emerling, Ann He, Junming Yang, Shanya D Becha, Ian J Forsythe, Ann E Gorvad, Jayalaxmi Ramkumar, Brendan M Duggan, Joana X Li, Jennifer A Griffin, April JA Hafalia, Joseph P Marquis
  • Publication number: 20040254350
    Abstract: various embodiments of the invention provide human immune response associated proteins (TRAP) and polynucleotides which identify and encode IRAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of IRAP.
    Type: Application
    Filed: March 19, 2004
    Publication date: December 16, 2004
    Inventors: Anne Ho, Mariah R Baughn, Shanya D Becha, Neil Burford, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe, Ann E Gorvad, Jennifer A Griffin, April JA Hafalia, Cynthia D Honchell, John D Burrill, Julie J Blake, Preeti G Lal, Ernestine A Lee, Joseph P Marquis, Patricia M Lehr-Mason, Sally Lee, William W Sprague, Anita Swarnakar, Y Tom Tang, Bao Tran, Uyen K Tran, Umesh G Bhatia, Narinder K Chawla, Bridget A Warren, Wenjin Zheng, Yuming Xu, Henry Yue
  • Publication number: 20040253588
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: August 28, 2003
    Publication date: December 16, 2004
    Inventors: Mariah R. Baughn, Christopher M. Bruns, Debopriya Das, Li Ding, Vicki S. Elliott, Ameena R. Gandhi, April J. A. Hafalia, Liam Kearney, Farrah A Khan, Preeti G. Lal, Ernestine A. Lee, Dyung Aina M. Lu, Yan Lu, Danniel B. Nguyen, Chandra S. Arvizu, Jayalaxmi Ramkumar, Huijun Z. Ring, Madhusudan M. Sanjanwala, Y.Tom Tang, Kavitha Tangavelu, Michael B. Thornton, Catherine M. Tribouley, Narinder K. Chawla, Yuming Xu, Junming Yang, Monique G. Yao, Henry Yue
  • Publication number: 20040249128
    Abstract: Various embodiments of the invention provide human molecules for disease detection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.
    Type: Application
    Filed: July 19, 2004
    Publication date: December 9, 2004
    Inventors: Michael B Thornton, Janice K Au-Young, Yalda Azimzai, Olga Bandman, Ines Barroso, Mariah R Baughn, Shanya D Becha, Mark L Borowsky, Li Ding, Brendan M Duggan, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe, Ameena R Gandhi, Kimberly J Gietzen, Ann E Gorvad, Jennifer A Griffin, Rajagopal Gururajan, April J A Hafalia, Huijun Z Ring, Craig H Ison, Karen Anne Jones, Preeti G Lal, Ernestine A Lee, Sally Lee, Joana X Li, Dyung Aina M Lu, Joseph P. Marquis, Patricia M. Lehr-Mason, Narinder K. Chawla, Chandra S. Arvizu, Bharati Sanjanwala, Thierry R. Sornasse, Anita Swarnakar, Y Tom Tang, Kavitha Thangavelu, Bao Tran, Uyen K. Tran, Bridget A. Warren, Yuming Xu, Monique G. Yao, Henry Yue, Huibin Yue, Yeganeh Zebarjadian, Hsin-Ru Chang
  • Publication number: 20040249127
    Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.
    Type: Application
    Filed: January 12, 2004
    Publication date: December 9, 2004
    Inventors: Olga Bandman, Mariah R. Baughn, Shanya D. Becha, Anna M. Chinn, Benjamin G. Cocks, Li Ding, Ian J. Forsythe, Kimberly J. Gietzen, Jennifer A. Griffin, April J. A. Hafalia, Farrah A. Khan, Preeti G. Lal, Ernestine A. Lee, Joana X. Li, Dyung Aina M. Lu, Jayalaxmi Ramkumar, Thomas W. Richardson, Anita Swarnakar, Y Tom Tang, Narinder K. Chawla, Bridget A. Warren, Junming Yang, Monique G. Yao, Henry Yue, Yeganeh Zebarjadian
  • Publication number: 20040248156
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to novel human C1q domain-containing polypeptides. Other aspects of the invention include vectors containing processes for producing novel human C1q domain-containing polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: January 16, 2004
    Publication date: December 9, 2004
    Inventors: Tianhua Hu, Y. Tom Tang, Malabika J. Ghosh, Jian-Rui Wang, Zhiwei Wang, Qing Zhao, Chongjun Xu, Julio Mulero
  • Publication number: 20040248243
    Abstract: The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with aberrant expression of LME.
    Type: Application
    Filed: July 11, 2002
    Publication date: December 9, 2004
    Inventors: Henry Yue, Jennifer L. Hillman, Mariah R. Baughn, Y. Tom Tang, Yalda Azimzai, Ameena R. Gandhi, Dyung Aina M. Lu, Danniel B. Nguyen, Narinder K. Walia
  • Publication number: 20040248249
    Abstract: Various embodiments of the invention provide human secreted proteins (SECP) and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: December 22, 2003
    Publication date: December 9, 2004
    Inventors: Uyen K Tran, Henry Yue, Bridget A Warren, Jennifer A Griffin, Thomas W Richardson, Ernestine A Lee, Mariah R Baughn, Neil Burford, Brendan M Duggan, Kavitha Thangavelu, Anita Swarnakar, Cynthia D Honchell, Roopa Reddy, Sally Lee, Kimberly J Gietzen, Y Tom Tang, Li Ding, Yalda Azimzai, Monique G Yao, Preeti G Lal, Brooke M Emerling, Yuming Xu, Ian J Forsythe, Vicki S Elliott, Shanya D Becha, Ameena R Gandhi, Patricia M Mason
  • Publication number: 20040248251
    Abstract: Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
    Type: Application
    Filed: July 7, 2004
    Publication date: December 9, 2004
    Inventors: Preeti G Lal, Cynthia D Honchell, Ian J Forsythe, Narinder K Chawla, Y Tom Tang, Mark L Borowsky, Ines Barroso, Henry Yue, Bridget A Warren, Kavitha Thangavelu, Kimberly J Gietzen, Yalda Azimzai, Ernestine A Lee, Mariah R Baughn, Ann E Gorvad, Brendan M Duggan, Bao Tran, Joana X Li, Thomas W Richardson, Vicki S Elliott, Yeganeh Zebarjadian, Uyen K Tran, Monique G Yao, David P Peterson, Wen Luo, Lehr-Mason Patricia
  • Patent number: 6824973
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human stem cell growth factor-like protein. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries from human testis cells (Hyseq clone identification numbers 2880984 and 2881695), from human fetal skin (Hyseq clone identification number 15375176), adult spleen (Hyseq clone identification number 14856094), and human endothelial cells (Hyseq clone identification numbers 13804756, 13687487, 13804756). Other aspects of the invention include vectors containing processes for producing novel human stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: November 30, 2004
    Assignees: Kirin Beer Kabushiki Kaisha, Nuvelo Inc.
    Inventors: Y. Tom Tang, Ivan Labat, Radoje T. Drmanac, Nancy Mize, Mitsuo Nishikawa, Cheng-Chi Chao
  • Publication number: 20040236090
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted fibulin-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from a cDNA library prepared from human thyroid gland mRNA (Clontech) (SEQ ID NO: 1). Other aspects of the invention include vectors containing processes for producing novel human secreted fibulin-like polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: May 28, 2004
    Publication date: November 25, 2004
    Inventors: Shubhada Godbola, Bryan J. Boyle, Chenghua Liu, Matthew Arterburn, Radoje T. Drmanac, Y. Tom Tang
  • Patent number: 6818754
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted semaphorin-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from fetal liver-spleen (Hyseq clone identification numbers 5688868 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted semaphorin-like polypeptides, and antibodies specific for such polypeptides.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: November 16, 2004
    Assignee: Nuvelo. Inc.
    Inventors: Bryan J. Boyle, George Yeung, Matthew C. Arterburn, Nancy K. Mize, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
  • Publication number: 20040224911
    Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
    Type: Application
    Filed: February 3, 2003
    Publication date: November 11, 2004
    Inventors: Henry Yue, Michael B. Thornton, Jayalxmi Ramkumar, Y.Tom Tang, Yalda Azimzai, Mariah R. Baughn, Junming Yang, Monique G. Yao, Preeti G. Lal, Narinder K. Chawla, Ameena R. Gandhi, April J. A. Hafalia, Danniel B. Nguyen, Chandra S. Arvizu, Vicki S. Elliott, Catherine M. Tribouley, Dyung Aina M. Lu, Yuming Xu, Roopa M. Reddy, Roberto Hernandez, Mark L. Borowsky, Terence P. Lo, Yan Lu, Jennifer L. Policky, Barrie D. Greene, Madhusudan M. Sanjanwala, Brigitte E. Raumann, Neil Burford, Craig H. Ison, Ernestine A. Lee, Li Ding, Debopriya Das, Deborah A. Kallick, Farrah A. Khan, Jeffrey J. Seilhamer
  • Publication number: 20040220383
    Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted semaphorin-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from fetal liver-spleen (Hyseq clone identification numbers 5688868 (SEQ ID NO. 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted semaphorin-like polypeptides, and antibodies specific for such polypeptides.
    Type: Application
    Filed: June 12, 2003
    Publication date: November 4, 2004
    Inventors: Bryan J. Boyle, George Yeung, Matthew C. Arterburn, Nancy K. Mize, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac